251 related articles for article (PubMed ID: 17517063)
81. A model for the study of hepatitis C virus entry.
Castet V; Moradpour D
Hepatology; 2003 Sep; 38(3):771-4. PubMed ID: 12939604
[TBL] [Abstract][Full Text] [Related]
82. Virolytic action of lipoprotein lipase on hepatitis C virus in human sera.
Thomssen R; Bonk S
Med Microbiol Immunol; 2002 May; 191(1):17-24. PubMed ID: 12137195
[TBL] [Abstract][Full Text] [Related]
83. Chylomicrons and lipoprotein lipase at the endothelial surface: bound and GAG-ged?
Ory DS
Cell Metab; 2007 Apr; 5(4):229-31. PubMed ID: 17403366
[TBL] [Abstract][Full Text] [Related]
84. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
[TBL] [Abstract][Full Text] [Related]
85. The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.
Goulbourne CN; Gin P; Tatar A; Nobumori C; Hoenger A; Jiang H; Grovenor CR; Adeyo O; Esko JD; Goldberg IJ; Reue K; Tontonoz P; Bensadoun A; Beigneux AP; Young SG; Fong LG
Cell Metab; 2014 May; 19(5):849-60. PubMed ID: 24726386
[TBL] [Abstract][Full Text] [Related]
86. High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.
Voisset C; de Beeck AO; Horellou P; Dreux M; Gustot T; Duverlie G; Cosset FL; Vu-Dac N; Dubuisson J
J Gen Virol; 2006 Sep; 87(Pt 9):2577-2581. PubMed ID: 16894196
[TBL] [Abstract][Full Text] [Related]
87. Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.
Zimmermann R; Panzenböck U; Wintersperger A; Levak-Frank S; Graier W; Glatter O; Fritz G; Kostner GM; Zechner R
Diabetes; 2001 Jul; 50(7):1643-53. PubMed ID: 11423487
[TBL] [Abstract][Full Text] [Related]
88. Chronic hepatitis C virus infection and lipoprotein metabolism.
Aizawa Y; Seki N; Nagano T; Abe H
World J Gastroenterol; 2015 Sep; 21(36):10299-313. PubMed ID: 26420957
[TBL] [Abstract][Full Text] [Related]
89. Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron.
Vivès RR; Lortat-Jacob H; Chroboczek J; Fender P
Virology; 2004 Apr; 321(2):332-40. PubMed ID: 15051392
[TBL] [Abstract][Full Text] [Related]
90. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.
Icard V; Diaz O; Scholtes C; Perrin-Cocon L; Ramière C; Bartenschlager R; Penin F; Lotteau V; André P
PLoS One; 2009; 4(1):e4233. PubMed ID: 19156195
[TBL] [Abstract][Full Text] [Related]
91. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.
Barth H; Schnober EK; Neumann-Haefelin C; Thumann C; Zeisel MB; Diepolder HM; Hu Z; Liang TJ; Blum HE; Thimme R; Lambotin M; Baumert TF
J Virol; 2008 Apr; 82(7):3466-79. PubMed ID: 18216094
[TBL] [Abstract][Full Text] [Related]
92. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells.
Krapp A; Zhang H; Ginzinger D; Liu MS; Lindberg A; Olivecrona G; Hayden MR; Beisiegel U
J Lipid Res; 1995 Nov; 36(11):2362-73. PubMed ID: 8656074
[TBL] [Abstract][Full Text] [Related]
93. Cellular metabolism of apoprotein-B containing lipoproteins: the role of apoproteins, heparan sulfate and cellular receptors.
Sehayek E
Isr J Med Sci; 1996 Jun; 32(6):445-8. PubMed ID: 8682649
[No Abstract] [Full Text] [Related]
94. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity.
Grove J; Huby T; Stamataki Z; Vanwolleghem T; Meuleman P; Farquhar M; Schwarz A; Moreau M; Owen JS; Leroux-Roels G; Balfe P; McKeating JA
J Virol; 2007 Apr; 81(7):3162-9. PubMed ID: 17215280
[TBL] [Abstract][Full Text] [Related]
95. Clathrin mediates infectious hepatitis C virus particle egress.
Benedicto I; Gondar V; Molina-Jiménez F; García-Buey L; López-Cabrera M; Gastaminza P; Majano PL
J Virol; 2015 Apr; 89(8):4180-90. PubMed ID: 25631092
[TBL] [Abstract][Full Text] [Related]
96. Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH.
Khan AG; Pichler J; Rosemann A; Blaas D
J Virol; 2007 May; 81(9):4625-32. PubMed ID: 17301156
[TBL] [Abstract][Full Text] [Related]
97. HCV Interplay with Lipoproteins: Inside or Outside the Cells?
Cosset FL; Mialon C; Boson B; Granier C; Denolly S
Viruses; 2020 Apr; 12(4):. PubMed ID: 32290553
[TBL] [Abstract][Full Text] [Related]
98. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
Foley EM; Esko JD
Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
[TBL] [Abstract][Full Text] [Related]
99. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.
Hishiki T; Shimizu Y; Tobita R; Sugiyama K; Ogawa K; Funami K; Ohsaki Y; Fujimoto T; Takaku H; Wakita T; Baumert TF; Miyanari Y; Shimotohno K
J Virol; 2010 Nov; 84(22):12048-57. PubMed ID: 20826689
[TBL] [Abstract][Full Text] [Related]
100. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity.
Zapatero-Belinchón FJ; Ötjengerdes R; Sheldon J; Schulte B; Carriquí-Madroñal B; Brogden G; Arroyo-Fernández LM; Vondran FWR; Maasoumy B; von Hahn T; Gerold G
Cells; 2021 Jun; 10(7):. PubMed ID: 34209751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
